A method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium

The problem of inaccurate results of existing methods when determining the dissolution amount of ipprazole enteric-coated tablets in pH 6.0 media was solved by liquid chromatography, and the main peak area was corrected by calculation formulas, which achieved accurate dissolution amount determination and formulation equivalent evaluation.

CN119757605APending Publication Date: 2025-04-04CHENGDU YAOYILIKANG PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510049587.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-01-13
Publication Date
2025-04-04

AI Technical Summary

Technical Problem

When the existing method determines the dissolution amount of esprazole enteric-coated tablets in a pH 6.0 medium, esprazole is extremely unstable and easy to degrade in the medium, resulting in inaccurate calculation results, which cannot accurately reflect the dissolution of esprazole enteric-coated tablets under the medium.

Method used

Liquid chromatography was used to simultaneously determine ipprazole and its degradation products, and the correspondence between the impurity peak area of ​​the degraded impurity and the main peak area of ​​the main component was established through the calculation formula, and the corrected main peak area was calculated, so as to accurately determine the dissolution amount of ipprazole enteric-coated tablets in pH 6.0 medium.

Benefits of technology

Through this method, the dissolution amount of esprazole enteric-coated tablets in pH 6.0 media can be accurately determined, which solves the problem of inaccurate results of the existing methods and provides a method to accurately evaluate whether the homemade preparation and reference preparation are equivalent.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119757605A_ABST
    Figure CN119757605A_ABST
Patent Text Reader

Abstract

The present invention discloses a method for determining the dissolution amount of ilaprazole enteric-coated tablets in a medium with a pH value of 6.0, comprising the following steps: (1) dissolving ilaprazole enteric-coated tablets in a medium with a pH value of 6.0 to obtain an ilaprazole solution; (2) determining the main peak area of ​​the main component and the impurity peak area of ​​the degradation impurities in the ilaprazole solution by liquid chromatography; (3) calculating the corrected main peak area; (4) calculating the dissolution amount of ilaprazole enteric-coated tablets in the medium with a pH value of 6.0 by using the corrected main peak area. The present invention adopts liquid chromatography to simultaneously determine ilaprazole and its degradation products, and uses a calculation formula to establish a corresponding relationship between the impurity peak area of ​​the degradation impurities and the main peak area of ​​the main component, thereby accurately determining and calculating the dissolution amount of ilaprazole enteric-coated tablets in the medium with a pH value of 6.0.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug analysis, and in particular relates to a method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium. Background Art

[0002] Ilaprazole enteric-coated tablets are drugs for the digestive tract and metabolism, and the main ingredient is ilaprazole. The ilaprazole in this product is an irreversible proton pump inhibitor of the benzimidazole class, which can selectively enter the gastric parietal cells and be converted into sulfonamide active metabolites, which react with the sulfhydryl groups on H+, K+-ATPase to form a covalent bond of disulfide bonds, irreversibly inhibiting H+, K+-ATPase and inhibiting gastric acid secretion.

[0003] There are reports on the detection method of the dissolution of ilaprazole enteric-coated tablets, all of which are detected by liquid chromatography, but the calculation method is directly calculated by the external standard method. Since ilaprazole is extremely unstable and easily degraded in pH 6.0, the results produced by this calculation method cannot accurately reflect the dissolution amount of ilaprazole enteric-coated tablets in this medium. This medium is the key to evaluating whether the homemade preparation is equivalent to the reference preparation. It is of certain significance to establish a method that can accurately determine the dissolution amount of ilaprazole in a pH 6.0 medium. Summary of the invention

[0004] In view of this, the object of the present invention is to provide a method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium, which can accurately determine and calculate the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium.

[0005] In order to achieve the above object, the present invention provides the following technical solutions:

[0006] The present invention discloses a method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium, comprising the following steps:

[0007] (1) dissolving ilaprazole enteric-coated tablets in a medium having a pH value of 6.0 to obtain an ilaprazole solution;

[0008] (2) determining the main peak area of ​​the main component and the impurity peak area of ​​the degradation impurities in the ilaprazole solution by liquid chromatography;

[0009] (3) Calculate the corrected main peak area using the following formula:

[0010] Corrected main peak area = (impurity 1 peak area + impurity 2 peak area + impurity 3 peak area) / correction factor + main peak area;

[0011] Correction factor = 0.49;

[0012] (4) The dissolution amount of ilaprazole enteric-coated tablets in pH 6.0 medium was calculated using the corrected main peak area.

[0013] As a preferred technical solution, in step (1), the medium with a pH value of 6.0 is a potassium dihydrogen phosphate buffer with a pH value of 6.0.

[0014] As a preferred technical solution, in step (1), potassium dihydrogen phosphate buffer with a pH of 12.5 is added immediately after dissolution sampling.

[0015] As a preferred technical solution, in step (2), the liquid chromatography detection conditions are:

[0016] Chromatographic column: chromatographic column using octadecylsilane bonded silica gel as filler;

[0017] Mobile phase A: a mixed solution of potassium dihydrogen phosphate and acetonitrile with a volume ratio of 90:10;

[0018] Mobile phase B: acetonitrile;

[0019] Flow rate: 1.0ml / min;

[0020] Injection volume: 20 μl;

[0021] Detection wavelength: 237nm;

[0022] Column temperature: 25°C;

[0023] Gradient elution program:

[0024]

[0025] As a preferred technical solution, in step (3), the relative retention time RRT of the impurity 1 peak is 0.42, the relative retention time RRT of the impurity 2 peak is 0.45, and the relative retention time RRT of the impurity 3 peak is 1.39.

[0026] The beneficial effects of the present invention are:

[0027] The present invention adopts liquid chromatography to simultaneously determine ilaprazole and its degradation products, and uses a calculation formula to establish a corresponding relationship between the impurity peak area of ​​the degradation impurity and the main peak area of ​​the main component, thereby accurately determining and calculating the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In order to make the purpose, technical solution and beneficial effects of the present invention clearer, the present invention provides the following drawings for illustration:

[0029] Figure 1 This is a typical chromatogram of ilaprazole sample;

[0030] Figure 2 The dissolution curve of ilaprazole enteric-coated tablets in pH 6.0 medium calculated by external standard method;

[0031] Figure 3 Figure 5 is the corrected dissolution curve of ilaprazole enteric-coated tablets in pH 6.0 medium. DETAILED DESCRIPTION

[0032] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0033] Example 1 Correspondence between the main peak area of ​​the main component of ilaprazole and the impurity peak area of ​​the degradation impurity

[0034] Ilaprazole has poor stability in a medium with a pH of 6.0 and is easily degraded, but has better stability in a medium with a high pH.

[0035] (1) The liquid chromatography detection conditions are as follows: the chromatographic column is filled with octadecylsilane bonded silica gel (YMC-Friart C18 4.6 mm*100 mm 3 μm); the mobile phase A is 0.02 mmol / L potassium dihydrogen phosphate solution (adjusted to pH 8.3 with sodium hydroxide)-acetonitrile (90:10), and the mobile phase B is acetonitrile; the flow rate is 1.0 ml per minute; the injection volume is 20 μl; the detection wavelength is 237 nm; and the column temperature is 25°C;

[0036] Perform linear gradient elution according to the following table:

[0037]

[0038] (2) Preparation of medium 1: 0.025 mol / L potassium dihydrogen phosphate (adjust the pH to 12.5 with sodium hydroxide).

[0039] (3) Preparation of medium 2: potassium dihydrogen phosphate buffer, pH 6.0.

[0040] (4) Preparation of medium 3: medium 1 - medium 2 (1:1).

[0041] (5) Preparation of reference stock solution: Weigh an appropriate amount of ilaprazole reference substance, dissolve it in acetonitrile and dilute it to a solution containing approximately 0.5 mg of ilaprazole per 1 ml.

[0042] (6) Preparation of test solution 1: Take 1 ml of the reference stock solution and place it in a 100 ml volumetric flask. Dilute to the mark with medium 3. Immediately take 2 ml and add 2 ml of medium 3. Mix well.

[0043] (7) Preparation of each test solution: Take 1 ml of the reference stock solution and place it in a 100 ml volumetric flask. Dilute to the mark with medium 2. Take 2 ml of the solution at 5 min, 10 min, 15 min, 20 min, 30 min, 45 min, and 60 min, add 2 ml of medium 1, and mix well.

[0044] (8) Liquid chromatography detection: Take the test solution 1 as the 0-hour test sample, and examine its stability at the same time, and take samples of each test solution in (7).

[0045] (9) The stability data of the test solution 1 is shown in Table 1:

[0046] Table 1 Stability data of test solution 1

[0047]

[0048]

[0049] According to the above test results, ilaprazole has good stability in medium 3 within 60 minutes.

[0050] (10) The typical chromatograms of the test solution in (7) are as follows Figure 1 As shown, the main component is ilaprazole, the relative retention time RRT of the impurity 1 peak is 0.42, the relative retention time RRT of the impurity 2 peak is 0.45, and the relative retention time RRT of the impurity 3 peak is 1.39.

[0051] The peak area data of each test solution in (7) are shown in Table 2:

[0052] Table 2 Peak area data of each test solution

[0053]

[0054] Calculate the correction factor using the following formula:

[0055]

[0056] The corrected main peak area was calculated using the following formula:

[0057] Corrected main peak area = (impurity 1 peak area + impurity 2 peak area + impurity 3 peak area) / correction factor + main peak area

[0058] Table 3 Correction factor calculation results

[0059]

[0060]

[0061] According to the above test results, the average correction factor of the sum of the three impurity peak areas within 60 minutes is 0.49, the ratio of the corrected main peak area to the 0h peak area is between 95% and 105%, and the sampling time of the dissolution curve in the pH 6.0 medium is within 60 minutes. This correction factor can be used to reflect the dissolution of ilaprazole.

[0062] Example 2 Determination and calculation of the dissolution amount of ilaprazole enteric-coated tablets in pH 6.0 medium

[0063] (1) Sample preparation: Dissolve ilaprazole enteric-coated tablets in medium 2 with a pH value of 6.0, take samples at different time points (sampling time is 5, 10, 15, 20, 30, 45, and 60 min), take 2 ml of the sample immediately, add 12 ml of the medium immediately, and mix well.

[0064] (2) Preparation of reference solution: Weigh an appropriate amount of ilaprazole reference substance and add acetonitrile to prepare a reference solution of appropriate concentration.

[0065] (3) The main peak area of ​​the main component and the impurity peak area of ​​the degradation impurities in ilaprazole enteric-coated tablets were determined using the liquid chromatography detection conditions provided in Example 1.

[0066] Figure 2 This is the dissolution curve of ilaprazole enteric-coated tablets in pH 6.0 medium calculated by the external standard method. The dissolution amount in the figure does not increase with time. It can be seen that this calculation method cannot well reflect the dissolution of ilaprazole enteric-coated tablets in Ph 6.0 medium.

[0067] The corrected main peak area was calculated using the following formula:

[0068] The corrected main peak area = (impurity 1 peak area + impurity 2 peak area + impurity 3 peak area) / correction factor + main peak area; correction factor = 0.49.

[0069] Figure 3 This is the corrected calculated dissolution curve of ilaprazole enteric-coated tablets in pH 6.0 medium. The dissolution curve can accurately show the dissolution of ilaprazole enteric-coated tablets in Ph 6.0 medium.

[0070] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.

Claims

1. A method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium, characterized in that: The following steps are involved: (1) Dissolve ilaprazole enteric-coated tablets in a solution of pH 6.0 medium to obtain ilaprazole solution; (2) determining the main peak area of ​​the main component and the impurity peak area of ​​the degradation impurities in the ilaprazole solution by liquid chromatography; (3) Calculate the corrected main peak area using the following formula: Corrected main peak area = (impurity 1 peak area + impurity 2 peak area + impurity 3 peak area) / correction factor + main peak area; correction factor = 0.49; (4) The dissolution amount of ilaprazole enteric-coated tablets in pH 6.0 medium was calculated using the corrected main peak area.

2. The method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium according to claim 1, characterized in that: In the step (1), the medium with a pH value of 6.0 is a potassium dihydrogen phosphate buffer with a pH value of 6.

0.

3. The method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium according to claim 1, characterized in that: In the step (1), potassium dihydrogen phosphate buffer with a pH of 12.5 is added immediately after dissolution sampling.

4. The method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium according to claim 1, characterized in that: In the step (2), the liquid chromatography detection conditions are: Chromatographic column: chromatographic column using octadecylsilane bonded silica gel as filler; Mobile phase A: a mixed solution of potassium dihydrogen phosphate and acetonitrile with a volume ratio of 90:10; Mobile phase B: acetonitrile; Flow rate: 1.0ml / min; Injection volume: 20 μl; Detection wavelength: 237nm; Column temperature: 25°C; Gradient elution program:

5. The method for determining the dissolution amount of ilaprazole enteric-coated tablets in a pH 6.0 medium according to any one of claims 1 to 4, characterized in that: In the step (3), the relative retention time RRT of the impurity 1 peak is 0.42, the relative retention time RRT of the impurity 2 peak is 0.45, and the relative retention time RRT of the impurity 3 peak is 1.39.